Fibrate use in the United States and Canada.
Publication
, Journal Article
Tenenbaum, A; Fisman, EZ
Published in: JAMA
July 13, 2011
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 13, 2011
Volume
306
Issue
2
Start / End Page
157
Location
United States
Related Subject Headings
- Practice Patterns, Physicians'
- Humans
- General & Internal Medicine
- Fibric Acids
- Fenofibrate
- Dyslipidemias
- Drug Utilization
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tenenbaum, A., & Fisman, E. Z. (2011). Fibrate use in the United States and Canada. JAMA, 306(2), 157. https://doi.org/10.1001/jama.2011.945
Tenenbaum, Alexander, and Enrique Z. Fisman. “Fibrate use in the United States and Canada.” JAMA 306, no. 2 (July 13, 2011): 157. https://doi.org/10.1001/jama.2011.945.
Tenenbaum A, Fisman EZ. Fibrate use in the United States and Canada. JAMA. 2011 Jul 13;306(2):157.
Tenenbaum, Alexander, and Enrique Z. Fisman. “Fibrate use in the United States and Canada.” JAMA, vol. 306, no. 2, July 2011, p. 157. Pubmed, doi:10.1001/jama.2011.945.
Tenenbaum A, Fisman EZ. Fibrate use in the United States and Canada. JAMA. 2011 Jul 13;306(2):157.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 13, 2011
Volume
306
Issue
2
Start / End Page
157
Location
United States
Related Subject Headings
- Practice Patterns, Physicians'
- Humans
- General & Internal Medicine
- Fibric Acids
- Fenofibrate
- Dyslipidemias
- Drug Utilization
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- 42 Health sciences